About us Contacts Drug interactions: 390 212
Drug search by name

Insulin glargine and lixisenatide Subcutaneous and Nuwiq (Antihemophilic Factor (Recombinant) (Nuwiq))

Determining the interaction of Insulin glargine and lixisenatide Subcutaneous and Nuwiq (Antihemophilic Factor (Recombinant) (Nuwiq)) and the possibility of their joint administration.

Check result:
Insulin glargine and lixisenatide Subcutaneous <> Nuwiq (Antihemophilic Factor (Recombinant) (Nuwiq))
Relevance: 04.04.2023 Reviewer: Shkutko P.M., M.D., in

No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.

Insulin glargine and lixisenatide Subcutaneous

Generic Name: insulin glargine / lixisenatide

Brand name: Soliqua 100/33

Synonyms: Insulin glargine and lixisenatide (Subcutaneous)

Nuwiq (Antihemophilic Factor (Recombinant) (Nuwiq))

Generic Name: antihemophilic factor

Brand name: Hemofil-M, Koate-DVI, Monoclate-P, Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Jivi, Obizur

Synonyms: Antihemophilic factor (human), Antihemophilic Factor (Human)

In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.